Скачать или смотреть EGFRm+ NSCLC: Should We Treat with Durvalumab? - ASCO Lung Review 2022

For this year's post-ASCO Lung Cancer roundtable review, Drs. H.Jack West, Oncologist with City of Hope Comprehensive Cancer Center and Founder and President of GRACE, Jarushka Naidoo, Medical Oncologist and Assistant Professor with Sidney Kimmel Cancer Center at Johns Hopkins, and Gilberto Lopes, Chief Medical Oncologist with Sylvester Comprehensive Cancer Center, discuss the newest updates in lung cancer, presented at ASCO 2022.

In this video Drs. West, Naidoo, and Lopes discuss the use of Durvalumab in patients with EGFRm+ NSCLC.

View transcript here: https://docs.google.com/document/d/1Q...

Thank you to our sponsors: #merck

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.